Impulse control disorders and dopamine agonists

Area of Science:

• Neuroendocrinology
• Behavioral Science

Background:

• Impulse control disorders (ICDs) are linked to dopamine agonist (DA) medications.
• DAs are frequently prescribed for prolactinoma, a common pituitary tumor.

Purpose of the Study:

• To review the prevalence of ICDs in pituitary tumor patients.
• To evaluate the association between DAs and ICDs.
• To outline clinical management and identify research gaps.

Main Methods:

• Narrative review of existing literature.
• Analysis of studies on ICD prevalence in pituitary tumor patients.
• Appraisal of evidence linking DAs to ICDs.

Main Results:

• Significant association noted between DA use and ICDs.
• Variability in reported ICD prevalence exists.
• Evidence supports a link, but further research is needed.

Conclusions:

• DA treatment for prolactinoma may elevate ICD risk.
• Clinical vigilance and further research are crucial for managing DA-associated ICDs.